Wall Street Hedge

Monday, April 12, 2021
Log in
  • Home
  • Nation & Politics
  • Financial News
  • Technology & Research
  • Lifestyle & Health
    • Latest News
      • Business
      • Nature
      • Science
      • World
      • VA Hospitals Are Still Under Investigation for Suspected Drug Thefts

Cancer Drug Spending Reaches $100B Mark

By Leave a Comment

1

As medicine prices continue to drop, spending on cancer drugs has reached a new milestone: $100 billion in 2014.

That’s more than 10 percent up from 2013, and a significant increase from $75 billion five years ago, announced a report published Tuesday by the IMS Institute for Healthcare Informatics. Targeted treatments, which target specific drivers of cancer, now claim almost half of total spending, IMS announced.

As more new cancer medicine gets approved, spending is likely to raise its pace. In the last five years, the average global growth rate on cancer medicines has been 6.5 percent, according to IMS. The research company predicts that rate to increase to 8 percent through 2018.

“Earlier diagnosis, longer treatment duration and increased effectiveness of drug therapies are contributing to rising levels of spending on medicines for cancer care. Measures of value continue to be tested by payers and providers who, in some health systems, most notably the U.S., have growing concerns about the financial burden faced by cancer patients,” IMS scientists, led by executive director Murray Aitken, wrote in the report’s summary.

Forty-five new drugs for cancer entered the market between the years 2010 and 2014, while 10 last hit the scene year alone. Two of those drugs are immunotherapies, a new class that stimulates the immune system to fight cancer. They are called Keytruda, from Merck, and Opdivo, from Bristol-Myers Squibb, and are very expensive: $12,500 a month.

Pharmacy benefits manager Express Scripts, which opposed new medicines for hepatitis C to obtain discounts last year, has mentioned that one of its next aims will be cancer medicines.

But with those high prices come important improvements in results. IMS says two thirds of Americans diagnosed with cancer ae now living at least five years, compared to just more than half a year in 1990.

“Although the changes are incremental year to year, cumulatively, more patients are gaining years of life,” IMS explained. It mentioned an 18 percent improvement was recorded in the five-year survival rate for prostate cancer patients from 1990 to 2010, while a 8 percent improvement was found in breast cancer and 12 percent in liver cancer.

Drug prices, especially in cancer, have been an increasing concern for years. The topic will be discussed at the largest annual cancer research conference, the American Society of Clinical Oncology meeting, a couple of weeks from now, in Chicago.

Image Source: Great News

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Financial News Tagged With: cancer, drug, expensive, medicine, prices, treatment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Recent Articles

AXA building in Wiesbaden, Germany.

Insurer AXA To Buy XL Group For $15 Billion

By Leave a Comment

New York Stock Exchange on Wall Street.

Wall Street Comes Out Intact As Global Stock Rise

By Leave a Comment

Ryanair profits are up despite threats of pilot strike.

Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

By Leave a Comment

Bitcoin bubble may burst, analysts speculate.

Bitcoin Bubble Shows Signs Of Bursting

By Leave a Comment

One percent amassed 82 percent of the world's fortune last year.

82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

By Leave a Comment

Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

By Leave a Comment

General Electric Laboratory

High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

By Leave a Comment

Cryptocurrency bitcoin coins

Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

By Leave a Comment

Computer circuit board

Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

By Leave a Comment

Thanksgiving dinner

Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

By Leave a Comment

Doctors in surgery

Vermont Is Preparing New Health Care System

By Leave a Comment

Saudi Arabia’s capital city Riyadh

Saudi Arabia Has Just Bought Huge Stake in Uber

By Leave a Comment

No Agreement Yet on the Trans-Pacific Partnership

By Leave a Comment

Samsung Shareholders Approve Deal Which Sees Lee Family Gain More Control

By Leave a Comment

Related Articles

  • AXA building in Wiesbaden, Germany.

    Insurer AXA To Buy XL Group For $15 Billion

  • New York Stock Exchange on Wall Street.

    Wall Street Comes Out Intact As Global Stock Rise

  • Ryanair profits are up despite threats of pilot strike.

    Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

  • Bitcoin bubble may burst, analysts speculate.

    Bitcoin Bubble Shows Signs Of Bursting

  • One percent amassed 82 percent of the world's fortune last year.

    82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

  • Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

    Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

  • General Electric Laboratory

    High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

  • Cryptocurrency bitcoin coins

    Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

  • Computer circuit board

    Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

  • Thanksgiving dinner

    Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

Categories

  • Business
  • Entertainment
  • Financial News
  • Lifestyle & Health
  • Nation & Politics
  • National News
  • Nature
  • Science
  • Technology & Research
  • World

Copyright © 2021 WallStreetHedge.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.